253 related articles for article (PubMed ID: 11323309)
1. Targeting polyamines of parasitic protozoa in chemotherapy.
Müller S; Coombs GH; Walter RD
Trends Parasitol; 2001 May; 17(5):242-9. PubMed ID: 11323309
[TBL] [Abstract][Full Text] [Related]
2. Polyamine metabolism as chemotherapeutic target in protozoan parasites.
Bacchi CJ; Yarlett N
Mini Rev Med Chem; 2002 Dec; 2(6):553-63. PubMed ID: 12370040
[TBL] [Abstract][Full Text] [Related]
3. Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets.
Coombs GH; Goldberg DE; Klemba M; Berry C; Kay J; Mottram JC
Trends Parasitol; 2001 Nov; 17(11):532-7. PubMed ID: 11872398
[TBL] [Abstract][Full Text] [Related]
4. Targeting DHFR in parasitic protozoa.
Anderson AC
Drug Discov Today; 2005 Jan; 10(2):121-8. PubMed ID: 15718161
[TBL] [Abstract][Full Text] [Related]
5. Polyamine transport in parasites: a potential target for new antiparasitic drug development.
Reguera RM; Tekwani BL; Balaña-Fouce R
Comp Biochem Physiol C Toxicol Pharmacol; 2005 Feb; 140(2):151-64. PubMed ID: 15907761
[TBL] [Abstract][Full Text] [Related]
6. DNA topoisomerases as targets for antiprotozoal therapy.
Bakshi RP; Shapiro TA
Mini Rev Med Chem; 2003 Sep; 3(6):597-608. PubMed ID: 12871162
[TBL] [Abstract][Full Text] [Related]
7. Content, synthesis, and function of polyamines in trypanosomatids: relationship to chemotherapy.
Bacchi CJ
J Protozool; 1981 Feb; 28(1):20-7. PubMed ID: 6788943
[No Abstract] [Full Text] [Related]
8. The acidocalcisome as a target for chemotherapeutic agents in protozoan parasites.
Docampo R; Moreno SN
Curr Pharm Des; 2008; 14(9):882-8. PubMed ID: 18473837
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrion of protozoan parasite emerges as potent therapeutic target: exciting drugs are on the horizon.
Sen N; Majumder HK
Curr Pharm Des; 2008; 14(9):839-46. PubMed ID: 18473833
[TBL] [Abstract][Full Text] [Related]
10. Targeting the cell cycle in the pursuit of novel chemotherapies against parasitic protozoa.
Grant KM
Curr Pharm Des; 2008; 14(9):917-24. PubMed ID: 18473840
[TBL] [Abstract][Full Text] [Related]
11. The cell cycle of parasitic protozoa: potential for chemotherapeutic exploitation.
Hammarton TC; Mottram JC; Doerig C
Prog Cell Cycle Res; 2003; 5():91-101. PubMed ID: 14593704
[TBL] [Abstract][Full Text] [Related]
12. Structural analysis of farnesyl pyrophosphate synthase from parasitic protozoa, a potential chemotherapeutic target.
Srivastava A; Mukherjee P; Desai PV; Avery MA; Tekwani BL
Infect Disord Drug Targets; 2008 Mar; 8(1):16-30. PubMed ID: 18473904
[TBL] [Abstract][Full Text] [Related]
13. New mechanisms of drug resistance in parasitic protozoa.
Borst P; Ouellette M
Annu Rev Microbiol; 1995; 49():427-60. PubMed ID: 8561467
[TBL] [Abstract][Full Text] [Related]
14. Understanding drug resistance in human intestinal protozoa.
El-Taweel HA
Parasitol Res; 2015 May; 114(5):1647-59. PubMed ID: 25782683
[TBL] [Abstract][Full Text] [Related]
15. Polyamine biosynthetic enzymes as drug targets in parasitic protozoa.
Heby O; Roberts SC; Ullman B
Biochem Soc Trans; 2003 Apr; 31(2):415-9. PubMed ID: 12653650
[TBL] [Abstract][Full Text] [Related]
16. Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites.
Ali V; Nozaki T
Clin Microbiol Rev; 2007 Jan; 20(1):164-87. PubMed ID: 17223627
[TBL] [Abstract][Full Text] [Related]
17. Polyamine homoeostasis as a drug target in pathogenic protozoa: peculiarities and possibilities.
Birkholtz LM; Williams M; Niemand J; Louw AI; Persson L; Heby O
Biochem J; 2011 Sep; 438(2):229-44. PubMed ID: 21834794
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural alterations in organelles of parasitic protozoa induced by different classes of metabolic inhibitors.
Rodrigues JC; de Souza W
Curr Pharm Des; 2008; 14(9):925-38. PubMed ID: 18473841
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapeutic approaches to protozoa: Giardia, Trichomonas and Entamoeba--current level of knowledge and outlook.
Harder A; Greif G; Haberkorn A
Parasitol Res; 2001 Sep; 87(9):785-6. PubMed ID: 11570567
[TBL] [Abstract][Full Text] [Related]
20. Drugs targeting parasite lysosomes.
Doyle PS; Sajid M; O'Brien T; Dubois K; Engel JC; Mackey ZB; Reed S
Curr Pharm Des; 2008; 14(9):889-900. PubMed ID: 18473838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
